Zhu Kai, Jogendran Manisha, Zhang Yanru, Hussaini Trana, Chahal Daljeet, Yoshida Eric M
Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Department of Medicine, Queen's University, Kingston, Ontario, Canada.
Can Liver J. 2025 Feb 25;8(1):8-17. doi: 10.3138/canlivj-2024-0009. eCollection 2025 Feb.
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 25% of Canadians. As its prevalence grows, it is crucial for future primary care physicians to have a thorough understanding of MASLD to improve patient care.
We conducted a nationwide cross-sectional survey among resident physicians in primary care specialties to assess their knowledge and perceptions of MASLD. "Reasonable knowledge" was defined as correctly answering over 50% of the questions. Associations were analyzed using χ testing and multiple logistic regression analysis.
We received 413 responses, with 252 (61%) from Family Medicine residents and 161 (39%) from Internal Medicine residents. Among the respondents, 91% considered MASLD an important public health issue; however, only 11% felt they had adequate exposure to the condition and 94% endorsed a need for more teaching. Overall, 35% of the respondents displayed a reasonable knowledge of MASLD. In univariate analysis, factors associated with greater MASLD knowledge included Internal Medicine residency ( = 0.001), higher post-graduate year ( = 0.003), prior GI or hepatology rotations ( = 0.003), previous MASLD lectures ( = 0.021), and higher subjective familiarity with MASLD ( <0.001). However, only moderate (odds ratio (OR) 5.7, 95% CI 1.1-26.3, = 0.026) and high (OR 10.1, CI 1.6-65.3, = 0.015) subjective familiarity with MASLD, and three or more prior MASLD lectures (OR 3.4, CI:1.1-10.4, = 0.031) remained statistically significant in multivariate analysis.
Resident physicians recognize MASLD as an important health issue but lack adequate exposure and knowledge about the condition. Further emphasis and education are required to bridge these knowledge gaps and improve patient outcomes.
代谢功能障碍相关脂肪性肝病(MASLD)影响着约25%的加拿大人。随着其患病率的上升,未来的初级保健医生全面了解MASLD对于改善患者护理至关重要。
我们对初级保健专业的住院医师进行了一项全国性横断面调查,以评估他们对MASLD的知识和认知。“合理知识”定义为正确回答超过50%的问题。使用χ检验和多元逻辑回归分析来分析相关性。
我们收到了413份回复,其中252份(61%)来自家庭医学住院医师,161份(39%)来自内科住院医师。在受访者中,91%认为MASLD是一个重要的公共卫生问题;然而,只有11%觉得他们对该疾病有足够的接触,94%认可需要更多的教学。总体而言,35%的受访者对MASLD表现出合理的知识。在单变量分析中,与更多MASLD知识相关的因素包括内科住院医师培训(P = 0.001)、更高的研究生年级(P = 0.003)、先前的胃肠病学或肝病学轮转(P = 0.003)、以前的MASLD讲座(P = 0.021)以及对MASLD更高的主观熟悉度(P <0.001)。然而,在多变量分析中,只有对MASLD的中度(优势比(OR)5.7,95%置信区间1.1 - 26.3,P = 0.026)和高度(OR 10.1,置信区间1.6 - 65.3,P = 0.015)主观熟悉度,以及三次或更多次以前的MASLD讲座(OR 3.4,置信区间:1.1 - 1o.4,P = 0.031)仍具有统计学意义。
住院医师认识到MASLD是一个重要的健康问题,但对该疾病缺乏足够的接触和知识。需要进一步加强和教育以弥补这些知识差距并改善患者预后。